Aug 7 |
EyePoint Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate Developments
|
Jul 15 |
Milestone Pharmaceuticals Refreshes Board of Directors
|
Jun 26 |
EyePoint Pharmaceuticals to Highlight DURAVYUâ„¢ (vorolanib intravitreal insert) Clinical and Regulatory Progress and Pipeline Innovation at R&D Day 2024
|
Jun 19 |
Intra-Cellular (ITCI) Soars 9.6%: Is Further Upside Left in the Stock?
|
Jun 18 |
EyePoint Pharmaceuticals to Host R&D Day on June 26, 2024
|
Jun 5 |
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
|
May 29 |
Investing in EyePoint Pharmaceuticals (NASDAQ:EYPT) a year ago would have delivered you a 91% gain
|
May 17 |
Insider Sale: Director David Guyer Sells Shares of EyePoint Pharmaceuticals Inc (EYPT)
|
May 16 |
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
|
May 10 |
EyePoint Pharmaceuticals Q1 2024 Earnings: Revenue Surpasses Estimates Despite Challenges
|